MTOR and liver cancer: It could also activate the adenosine monophosphate-activated protein kinase/mechanistic target of rapamycin (AMPK/mTOR) signaling pathway to inhibit autophagy in HepG2 cells, exhibiting excellent potential for use in the treatment of liver cancer [73].